Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
Clinical trial NCT00321646 · COMPLETED
Trial details
- NCT number
- NCT00321646
- Sponsor
- Mary-Ellen Taplin, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.